Screening for late effects in brain tumor survivors

Cancer Treatment and Research

Volumn 150, Issue , 2009, Pages 389-409

  Landier, Wendy ^a   Kinahan, Karen E ^b,c   Shaw, Susan ^d   Bhatia, Smita ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Survivors Taking Action Responsibility   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; BRAIN TUMOR; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHILD; CHRONIC BRAIN DISEASE; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GERM CELL TUMOR; GROWTH DISORDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; MEDULLOBLASTOMA; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; PATIENT EDUCATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RADIATION INJURY; REVIEW; SKULL IRRADIATION; STEM CELL TRANSPLANTATION; SURVIVOR;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN DAMAGE, CHRONIC; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; GERMINOMA; GROWTH DISORDERS; HUMANS; KIDNEY DISEASES; MEDULLOBLASTOMA; NEUROSURGICAL PROCEDURES; PATIENT EDUCATION AS TOPIC; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES AS TOPIC; RADIATION INJURIES; STEM CELL TRANSPLANTATION; SURVIVORS; TRANSPLANTATION CONDITIONING;

EID: 77956640974     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/b109924_26     Document Type: Article

References (53)

1. Blaney SM, Kun LE, Hunter J, et al. Tumors of the central nervous system. In: Pizzo PA, Poplack DA, eds. Principles and Practice of Pediatric Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006:786-864.
2. Sklar CA, Mertens AC, Mitby P, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98: 890-896. (Pubitemid 44018918)
3. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005:12-17.
4. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer.2003;97:663-673. (Pubitemid 36125844)
5. Cheruku R, Hussain M, Tyrkus M, et al. Myelodysplastic syndrome after cisplatin therapy. Cancer.1993;72:213-218. (Pubitemid 23182075)
6. Pui CH. Epipodophyllotoxin-related acute myeloid leukaemia. Lancet.1991;338:1468.
7. Stillwell TJ, Benson RC, Jr. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer.1988;61:451-457. (Pubitemid 18039357)
8. Bianchetti MG, Kanaka C, Ridolfi-Luthy A, et al. Persisting renotubular sequelae after cisplatin in children and adolescents. Am J Nephrol.1991;11:127- 130.
9. Schell MJ, McHaney VA, Green AA, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol.1989;7: 754-760. (Pubitemid 19145597)
10. Hilkens PH, ven den Bent MJ. Chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst.1997;2:350-361. (Pubitemid 127687133)
11. Ellis PA, Fitzharris BM, George PM, et al. Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors. J Clin Oncol.1992;10: 1609-1614. (Pubitemid 23057991)
12. Mertens AC, Yasui Y, Liu Y, et al. Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer. 2002;95:2431-2441. (Pubitemid 35351152)
13. Piel B, Vaidya S, Lancaster D, et al. Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia. Br J Haematol.2004;125:410-411; author reply 2.
14. Aisenberg J, Hsieh K, Kalaitzoglou G, et al. Bone mineral density in young adult survivors of childhood cancer. J Pediatr Hematol Oncol.1998;20:241-245. (Pubitemid 28280901)
15. Hurel SJ, Kendall-Taylor P. Avascular necrosis secondary to postoperative steroid therapy. Br J Neurosurg.1997;11:356-358. (Pubitemid 27321072)
16. Kaye LD, Kalenak JW, Price RL, et al. Ocular implications of long-term prednisone therapy in children. J Pediatr Ophthalmol Strabismus. 1993;30:142-144. (Pubitemid 23177606)
17. Neglia JP, Friedman DL, Yutaka Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst. 2001;93:618-629. (Pubitemid 32409629)
18. Lawenda BD, Gagne HM, Gierga DP, et al. Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys. 2004;60:879-887. (Pubitemid 39311769)
19. Reimers TS, Ehrenfels S, Mortensen EL, et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Medical and pediatric oncology. 2003;40:26-34. (Pubitemid 35340564)
20. Matsumoto K, Takahashi S, Sato A, et al. Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy - an MR analysis. Int J Radiat Oncol Biol Phys. 1995;32:913-918.
21. Grenier Y, Tomita T, Marymont MH, et al. Late postirradiation occlusive vasculopathy in childhood medulloblastoma. J Neurosurg.1998;89:460-464. (Pubitemid 28405262)
22. Kestle JR, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg.1993;79:32-35. (Pubitemid 23182740)
23. Bowers DC, Liu Y, Leisenring W, et al. Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol.2006;24:5277-5282. (Pubitemid 46631374)
24. Kaste SC, Chen G, Fontanesi J, et al. Orbital development in long-term survivors of retinoblastoma. J Clin Oncol.1997;15:1183-1189. (Pubitemid 27106306)
25. Ellingwood KE, Million RR. Cancer of the nasal cavity and ethmoid/sphenoid sinuses. Cancer.1979;43:1517-1526. (Pubitemid 9178535)
26. Parsons JT, Bova FJ, Mendenhall WM, et al. Response of the normal eye to high dose radiotherapy. Oncology(Williston Park, NY). 1996;10:837-847; discussion 47-48, 51-52.
27. Johannesen TB, Rasmussen K, Winther FO, et al. Late radiation effects on hearing, vestibular function, and taste in brain tumor patients. Int J Radiat Oncol Biol Phys. 2002;53:86-90. (Pubitemid 34465810)
28. Guchelaar HJ, Vermes A, Meerwaldt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Support Care Cancer.1997;5:281-288. (Pubitemid 27305078)
29. Sonis AL, Tarbell N, Valachovic RW, et al. Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities. Cancer.1990;66:2645-2652.
30. Nasman M, Forsberg CM, Dahllof G. Long-term dental development in children after treatment for malignant disease. Eur J Orthod.1997;19:151-159. (Pubitemid 127493948)
31. Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;328:87-94.
32. Nuver J, Smit AJ, Postma A, et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treatment Rev. 2002;28:195-214. (Pubitemid 35244128)
33. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys. 1995;31:1113-1121.
34. Packer RJ, Boyett JM, Janss AJ, et al. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol.2001;19:480-487. (Pubitemid 32112862)
35. Oberfield SE, Soranno D, Nirenberg A, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr AdolescentMed. 1996;150:589-592. (Pubitemid 26196768)
36. Livesey EA, Brook CG. Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours. Arch Dis Child.1989;64:593-595. (Pubitemid 19104123)
37. Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocrine-related Cancer. 2004;11:589-602. (Pubitemid 40065540)
38. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, et al. Assessment of the hypothalamo- pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metabolism. 2003;88:3149-3154. (Pubitemid 36877487)
39. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1-7.
40. Carpentieri SC, Waber DP, Pomeroy SL, et al. Neuropsychological functioning after surgery in children treated for brain tumor. Neurosurgery.2003;52:1348-1356; discussion 56-57.
41. Sonderkaer S, Schmiegelow M, Carstensen H, et al. Long-term neurological outcome of childhood brain tumors treated by surgery only. J Clin Oncol.2003;21:1347-1351. (Pubitemid 46606414)
42. Cassidy L, Stirling R, May K, et al. Ophthalmic complications of childhood medulloblastoma. Med Pediatr Oncol.2000;34:43-47. (Pubitemid 30022708)
43. Miller JS, Arthur DC, Litz CE, et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood.1994;83:3780-3786. (Pubitemid 24175569)
44. Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol.2001;19:464-471. (Pubitemid 32112860)
45. Baker KS, DeFor TE, Burns LJ, et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol.2003;21: 1352-1358. (Pubitemid 46606415)
46. McKay PJ, Murphy JA, Cameron S, et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant.1996; 17:63-66. (Pubitemid 26031892)
47. Tauchmanova L, De Rosa G, Serio B, et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer.2003;97:2453-2461. (Pubitemid 36542484)
48. Sklar C, Boulad F, Small T, et al. Endocrine complications of pediatric stem cell transplantation. Front Biosci.2001;6:G17-G22.
49. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582. (Pubitemid 44547808)
50. Children's Oncology Group: Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers, Version 3.0. September 2008, www.survivor shipguidelines.org
51. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol.2004;22:4979-4990. (Pubitemid 46638624)
52. Eshelman D, Landier W, Sweeney T, et al. Facilitating care for childhood cancer survivors: integrating children's oncology group long-term follow-up guidelines and health links in clinical practice. J Pediatr Oncol Nurs.2004;21:271-280. (Pubitemid 39256288)
53. Hewitt ME, Greenfield S, Stovall E, eds. From cancer patient to cancer survivor: lost in transition: Institute of Medicine. Washington, DC: The National Academies Press; 2006.